Advertisement

Picture EBD Group BioPharm America 2019 Boston September 650x65px
Organisation › Details

Compugen (Group)

Compugen is a leading therapeutic discovery company utilizing its broadly applicable predictive discovery infrastructure to identify novel drug targets and develop first-in-class biologics. The primary focus of the Company’s current pipeline is on immune checkpoint target candidates discovered by the Company, potentially providing the basis for a next wave of therapeutics for cancer immunotherapy. Compugen’s business model is based on selectively entering into collaborations for its novel target candidates and drug product candidates at various stages of research and development under revenue-sharing agreements. The Company is headquartered in Israel, with R&D facilities in Israel and South San Francisco. At the US facilities, monoclonal antibody therapeutic candidates are discovered and developed against the Company’s novel target candidates. *

 

Period Start 2000-03-11 existent
Product Industry bioinformatics (biological software and databases)
Person Person Cohen-Dayag, Anat (Compugen 201112 CEO)
     
  Street 26 Harokmim Street
  City 5885849 Holon
  Tel +972-3-765-8585
    Address record changed: 2018-07-24
     
Basic data Employees D: 101 to 500 (2017-12-31)
  Currency USD
  Profit -37,066,000 (2017-12-31)
  Cash 25,470,000 (2017-12-31)
     
    * Document for �About Section�: 
     
   
Record changed: 2018-04-03

Advertisement

Picture [LSS] Life-Sciences-Scandinavia.com – The Business Web Portal 560x95px

More documents for Compugen (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

Picture EBD Group BioPharm America 2019 Boston September 650x65px




» top